OrphanDrug
OrphanDrug
Pharma Knowledge Base

dystrophic epidermolysis bullosa pruriginosa

MeSH: C563192ORPHA: 89843

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Dystrophic epidermolysis bullosa pruriginosa is a rare subtype of dystrophic epidermolysis bullosa (DEB, see this term) characterized by generalized or localized skin lesions associated with severe, if not intractable, pruritus

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with dystrophic epidermolysis bullosa pruriginosa, sourced from HPO and Orphanet clinical annotations.

PruritusAbnormal blistering of the skinAbnormality of the wristNail dystrophyAbnormality of the elbowPretibial blisteringLichenificationSkin plaqueAbnormality of head or neckHyperkeratosisMiliaAtrophic scarsSubcutaneous noduleAbnormal forearm morphologyLamina lucida cleavageDermal atrophyAbnormal toenail morphologyScarringPapuleIncreased circulating IgE concentration

Classification & Codes

MeSH Code

C563192

Orphanet Code

ORPHA:89843
dystrophic epidermolysis bullosa pruriginosa
MeSHC563192
OrphanetORPHA:89843
Treatments0 drug(s)
Symptoms on record20 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO